BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9525820)

  • 1. Chemotherapy in experimental brain tumor, part 1: in vitro colorimetric MTT assay.
    Hand CM; Vender JR; Black P
    J Neurooncol; 1998 Jan; 36(1):1-6. PubMed ID: 9525820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy in experimental brain tumor, part 2: pretreatment with leukotriene C4 prolongs survival.
    Black P; Hand CM; Vender JR; Finkelstein SD
    J Neurooncol; 1998 Jan; 36(1):7-19. PubMed ID: 9525821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay.
    Jordan JP; Hand CM; Markowitz RS; Black P
    J Neurooncol; 1992 Sep; 14(1):19-35. PubMed ID: 1335043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part II: Evaluation of patient- and drug-specific variables.
    Nikkhah G; Tonn JC; Hoffmann O; Kraemer HP; Darling JL; Schachenmayr W; Schönmayr R
    J Neurooncol; 1992 May; 13(1):13-24. PubMed ID: 1613536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of glioma cell death by 1,25(OH)2 vitamin D3: towards an endocrine therapy of brain tumors?
    Naveilhan P; Berger F; Haddad K; Barbot N; Benabid AL; Brachet P; Wion D
    J Neurosci Res; 1994 Feb; 37(2):271-7. PubMed ID: 8151734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium succinate enhances the colorimetric reaction of the in vitro chemosensitivity test: MTT assay.
    Maehara Y; Kusumoto T; Kusumoto H; Anai H; Sugimachi K
    Oncology; 1988; 45(6):434-6. PubMed ID: 3186153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
    Fang KM; Lin TC; Chan TC; Ma SZ; Tzou BC; Chang WR; Liu JJ; Chiou SH; Yang CS; Tzeng SF
    Glia; 2013 Sep; 61(9):1402-17. PubMed ID: 23832679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro chemosensitivity testing and its clinical application in human gliomas.
    Yung WK
    Neurosurg Rev; 1989; 12(3):197-203. PubMed ID: 2682352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo cytotoxicity of gossypol against central nervous system tumor cell lines.
    Coyle T; Levante S; Shetler M; Winfield J
    J Neurooncol; 1994; 19(1):25-35. PubMed ID: 7815102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.
    Carmichael J; DeGraff WG; Gazdar AF; Minna JD; Mitchell JB
    Cancer Res; 1987 Feb; 47(4):936-42. PubMed ID: 3802100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination effect of hyperthermia and MX2 on cultured glioma cell lines].
    Mizumatsu S; Ono Y; Tamiya T; Matsumoto K; Ohmoto T; Furuta T
    Gan To Kagaku Ryoho; 1999 May; 26(6):789-95. PubMed ID: 10410148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a rapid tetrazolium-based colorimetric assay for selecting anticancer drugs.
    Chen CF; Hwang JM; Wu CH; Chen CS; Chen KY
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Jul; 46(1):7-16. PubMed ID: 2176928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin enhances glioma growth.
    Hua Y; Tang L; Keep RF; Hoff JT; Heth J; Xi G; Muraszko KM
    Acta Neurochir Suppl; 2008; 102():363-6. PubMed ID: 19388346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of tetrazolium colorimetric and [3H]-uridine assays for in vitro chemosensitivity testing.
    Ford CH; Richardson VJ; Tsaltas G
    Cancer Chemother Pharmacol; 1989; 24(5):295-301. PubMed ID: 2788039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibition and chemosensitization of exogenous nitric oxide released from NONOates in glioma cells in vitro.
    Weyerbrock A; Baumer B; Papazoglou A
    J Neurosurg; 2009 Jan; 110(1):128-36. PubMed ID: 18991497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay of anticancer drugs in tissue culture: comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma.
    Haselsberger K; Peterson DC; Thomas DG; Darling JL
    Anticancer Drugs; 1996 May; 7(3):331-8. PubMed ID: 8792008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic and genotoxic effects of [Ru(phi)3]2+ evaluated by Ames/Salmonella and MTT methods.
    Benkli K; Tunali Y; Cantürk Z; Artagan O; Alanyali F
    Eur J Med Chem; 2009 Jun; 44(6):2601-5. PubMed ID: 18947906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemosensitivity testing of clinical gastrointestinal cancers using histoculture and the MTT end-point.
    Furukawa T; Kubota T; Watanabe M; Kase S; Takahara T; Yamaguchi H; Takeuchi T; Teramoto T; Ishibiki K; Kitajima M
    Anticancer Res; 1992; 12(5):1377-82. PubMed ID: 1444194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemosensitivity and radiosensitivity of small cell lung cancer cell lines studied by a newly developed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) hybrid assay.
    Hida T; Ueda R; Takahashi T; Watanabe H; Kato T; Suyama M; Sugiura T; Ariyoshi Y; Takahashi T
    Cancer Res; 1989 Sep; 49(17):4785-90. PubMed ID: 2547517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of selenium on malignant tumor cells of brain.
    Zhu Z; Kimura M; Itokawa Y; Nakatsu S; Oda Y; Kikuchi H
    Biol Trace Elem Res; 1995 Jul; 49(1):1-7. PubMed ID: 7577318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.